Abstract:Recent advances in computational methods provide the promise of dramatically accelerating drug discovery. While mathematical modeling and machine learning have become vital in predicting drug-target interactions and properties, there is untapped potential in computational drug discovery due to the vast and complex chemical space. This paper builds on our recently published computational fragment-based drug discovery (FBDD) method called fragment databases from screened ligand drug discovery (FDSL-DD). FDSL-DD uses in silico screening to identify ligands from a vast library, fragmenting them while attaching specific attributes based on predicted binding affinity and interaction with the target subdomain. In this paper, we further propose a two-stage optimization method that utilizes the information from prescreening to optimize computational ligand synthesis. We hypothesize that using prescreening information for optimization shrinks the search space and focuses on promising regions, thereby improving the optimization for candidate ligands. The first optimization stage assembles these fragments into larger compounds using genetic algorithms, followed by a second stage of iterative refinement to produce compounds with enhanced bioactivity. To demonstrate broad applicability, the methodology is demonstrated on three diverse protein targets found in human solid cancers, bacterial antimicrobial resistance, and the SARS-CoV-2 virus. Combined, the proposed FDSL-DD and a two-stage optimization approach yield high-affinity ligand candidates more efficiently than other state-of-the-art computational FBDD methods. We further show that a multiobjective optimization method accounting for drug-likeness can still produce potential candidate ligands with a high binding affinity. Overall, the results demonstrate that integrating detailed chemical information with a constrained search framework can markedly optimize the initial drug discovery process, offering a more precise and efficient route to developing new therapeutics.

MolOptimizer: A Molecular Optimization Toolkit for Fragment-Based Drug Design

Streamlining Computational Fragment-Based Drug Discovery Through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening

Fragment-Masked Molecular Optimization

Fragment-Based Ligand Generation Guided By Geometric Deep Learning On Protein-Ligand Structure

MolDesigner: Interactive Design of Efficacious Drugs with Deep Learning

CASTELO: Clustered Atom Subtypes aidEd Lead Optimization -- a combined machine learning and molecular modeling method

BuildAMol: A versatile Python toolkit for fragment-based molecular design

Latent Molecular Optimization for Targeted Therapeutic Design

Optimizing molecules using efficient queries from property evaluations

Leveraging language model for advanced multiproperty molecular optimization via prompt engineering

CLigOpt: controllable ligand design through target-specific optimization

MolSnapper: Conditioning Diffusion for Structure Based Drug Design

DockOpt: A Tool for Automatic Optimization of Docking Models

LIMO: Latent Inceptionism for Targeted Molecule Generation

ChemMORT: an automatic ADMET optimization platform using deep learning and multi-objective particle swarm optimization

OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds

molli: A General-Purpose Python Toolkit for Combinatorial Small Molecule Library Generation, Manipulation, and Feature Extraction.

A Deep Generative Model for Molecule Optimization via One Fragment Modification

ChemoDOTS: a web server to design chemistry-driven focused libraries

Efficient Exploration of Chemical Space with Docking and Deep Learning

AMPL: A Data-Driven Modeling Pipeline for Drug Discovery